北大医药：第三季度净利润同比下降18.04%

Core Viewpoint - The company reported a significant decline in revenue and net profit for the third quarter, indicating potential challenges in its operational performance [1] Financial Performance - In Q3, the company achieved a revenue of 274 million, a year-on-year decrease of 47.95% [1] - The net profit attributable to shareholders for Q3 was 35.6867 million, down 18.04% year-on-year [1] - For the first three quarters, the company reported a total revenue of 1.231 billion, reflecting a year-on-year decline of 19.76% [1] - The net profit attributable to shareholders for the first three quarters was 136 million, which represents a year-on-year increase of 4.31% [1]